Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim for platelet engraftment after hematopoietic stem cell transplantation
ChiCTR2600130800Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Feb 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of romiplostim in hematopoietic malignancies (3 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Time to platelet engraftment. Started Feb 2025; status: completed.
02
Drugs
romiplostim
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on ChiCTR2600130800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600130800.